Skye Bioscience, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Skye Bioscience, Inc. (SKYE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $916.33 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-10
- Skye Bioscience, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2025 was $916.33K.
- Skye Bioscience, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Skye Bioscience, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $35.62K, a 3.01% decline from fiscal 2021.
- Skye Bioscience, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $36.73K, a 8.27% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $916.33K 10-K · filed 2026-03-10 | |
| 2023-12-31 | $0.00 10-K · filed 2024-03-22 | |
| 2022-12-31 | $35.62K 10-K · filed 2024-03-22 | |
| 2021-12-31 | $36.73K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $33.92K 10-K · filed 2022-03-28 | $22.66K 10-K · filed 2021-03-02 |
| 2019-12-31 | -$1.35K 10-K · filed 2021-03-02 | |
| 2018-12-31 | $629.00 10-K · filed 2020-03-23 | $127.83K 10-K · filed 2019-03-14 |
| 2017-12-31 | $12.00 10-K · filed 2019-03-14 | |
| 2016-12-31 | $4.25K 10-K · filed 2018-03-19 | $1.58K 10-K · filed 2017-03-10 |
| 2015-12-31 | $222.21K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |